- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05230875
Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial (SexIA-CT)
September 27, 2022 updated by: University Hospital, Bordeaux
Patients with Inflammatory Bowel Disease (IBD) have higher rates of sexual dysfunction than the general population.
We offer an educational program on IBD including a specific discussion on intimacy and sexuality for IBD patients.
Our objective is to investigate the benefit of this intervention on sexual function in patients with IBD.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Patients with Inflammatory Bowel Disease (IBD) have higher rates of sexual dysfunction than healthy controls.
No interventional study has addressed this matter so far.
The aim of our study is to investigative the benefit of a psycho-educational intervention on sexual function in patients with IBD, by comparing patients participating to an educational program including a specific discussion on intimacy and sexuality to patients followed in usual care.
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pauline RIVIERE
- Phone Number: 0557656439
- Email: pauline.riviere@chu-bordeaux.fr
Study Locations
-
-
-
Talence, France, 33400
- Recruiting
- Centre Hospitalier Universitaire de Bordeaux
-
Contact:
- Pauline RIVIERE
- Phone Number: 0557656439
- Email: pauline.riviere@chu-bordeaux.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient with Crohn's disease or Ulcerative Colitis diagnosed according to usual criteria.
Description
Inclusion Criteria:
- Age > 18 years
- Crohn's disease or Ulcerative Colitis diagnosed according to usual criteria
- Participation to IBD educational program
Exclusion Criteria:
- Unability to read or write French
- Patients without sexual activity for religious reasons
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients participating in the therapeutic education program
Patients participating in an educational program on Inflammatory Bowel Disease (IBD) including a specific discussion on intimacy and sexuality .
|
All patients participating in the therapeutic education program will complete a self-administered questionnaire before participation in educational program. A new identical self-questionnaire will be distributed to patients 3 to 6 months after their participation in the therapeutic education program. |
|
Patients control (not participating in the therapeutic education program)
A control group (at the rate of two controls for one case) will be made up of IBD patients routinely followed in the gastroenterology department.Those patients will not participate in the therapeutic education program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean scores of sexual function scores using International Index of Erectile Function (IIEF) for men
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Mean scores of sexual function scores using International Index of Erectile Function (IIEF) for men
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
|
Mean scores of sexual function scores using Female Sexual Function Index (FSFI) for women.
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Mean scores of sexual function scores using Female Sexual Function Index (FSFI) for women.
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean scores for quality of life (S-IBDQ)
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Mean scores for quality of life (S-IBDQ)
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
|
Mean scores for anxiety and depression (HADS)
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Mean scores for anxiety and depression (HADS)
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
|
Mean scores for fatigue (FSS)
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Mean scores for fatigue (FSS)
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
|
Means score for body image (BIS).
Time Frame: before participation to educational program
|
before participation to educational program
|
|
Means score for body image (BIS).
Time Frame: from 3 to 6 months after participation to educational program.
|
from 3 to 6 months after participation to educational program.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 7, 2022
Primary Completion (Anticipated)
September 5, 2023
Study Completion (Anticipated)
September 5, 2023
Study Registration Dates
First Submitted
December 2, 2021
First Submitted That Met QC Criteria
January 27, 2022
First Posted (Actual)
February 9, 2022
Study Record Updates
Last Update Posted (Actual)
September 28, 2022
Last Update Submitted That Met QC Criteria
September 27, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2021/16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Xijing HospitalNot yet recruitingInflammatory Bowel Diseases (IBD)China
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Texas Southwestern Medical CenterEnrolling by invitationInflammatory Bowel Disease | Inflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
Clinical Trials on self-administered questionnaire
-
University Hospital, LilleFondation Santé RoquetteCompleted
-
Alaa Mohammed YehiaCompletedMolar Incisor Hypomineralization | Dental Enamel HypoplasiaEgypt
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingSquamous Cell Carcinoma of the Anal Canal | HPV-induced Cancer
-
Central Hospital, Nancy, FranceCompletedAtopic DermatitisFrance
-
University Hospital, BordeauxRecruitingSpinal Stenosis | Vertebral Osteomyelitis | SPINAL Fracture | Vertebral MetastasisFrance
-
Sohag UniversityNot yet recruitingQuality of Life | Health Anxiety
-
Sohag UniversityNot yet recruiting
-
Centre Hospitalier Charles Perrens, BordeauxRégion Nouvelle Aquitaine; Regional Health Agency New AquitaineNot yet recruitingCovid19 | Work-Related Condition | Work-Related Stress Disorder | Personnel, Hospital
-
University Hospital, MontpellierTerminated